Man Group plc raised its holdings in shares of Genpact Limited (NYSE:G - Free Report) by 51.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 81,306 shares of the business services provider's stock after acquiring an additional 27,684 shares during the quarter. Man Group plc's holdings in Genpact were worth $3,492,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also made changes to their positions in G. Coppell Advisory Solutions LLC grew its stake in shares of Genpact by 529.5% in the fourth quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider's stock valued at $25,000 after buying an additional 503 shares in the last quarter. SRH Advisors LLC bought a new position in shares of Genpact in the fourth quarter valued at $26,000. Atlas Capital Advisors Inc. grew its stake in shares of Genpact by 55.8% in the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock valued at $26,000 after buying an additional 216 shares in the last quarter. Manchester Capital Management LLC bought a new position in shares of Genpact in the fourth quarter valued at $38,000. Finally, GeoWealth Management LLC lifted its holdings in Genpact by 199.0% during the 4th quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock valued at $38,000 after purchasing an additional 583 shares during the last quarter. 96.03% of the stock is owned by institutional investors.
Genpact Stock Performance
Shares of G traded down $0.02 during midday trading on Friday, reaching $43.50. 945,783 shares of the stock were exchanged, compared to its average volume of 1,369,261. Genpact Limited has a twelve month low of $30.38 and a twelve month high of $56.76. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50. The company has a market cap of $7.61 billion, a P/E ratio of 15.32, a PEG ratio of 1.84 and a beta of 1.02. The stock's 50 day simple moving average is $47.42 and its 200 day simple moving average is $47.36.
Genpact (NYSE:G - Get Free Report) last posted its earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share for the quarter, topping analysts' consensus estimates of $0.80 by $0.04. Genpact had a return on equity of 22.50% and a net margin of 10.77%. The company had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.21 billion. During the same quarter last year, the firm earned $0.73 earnings per share. The company's revenue was up 7.4% on a year-over-year basis. On average, sell-side analysts expect that Genpact Limited will post 3.21 earnings per share for the current year.
Insider Transactions at Genpact
In related news, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the transaction, the chief executive officer now owns 310,246 shares in the company, valued at approximately $15,167,926.94. This trade represents a 4.20% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Nicholas C. Gangestad purchased 2,000 shares of the firm's stock in a transaction that occurred on Tuesday, May 13th. The stock was bought at an average price of $43.97 per share, for a total transaction of $87,940.00. Following the transaction, the director now directly owns 2,000 shares of the company's stock, valued at $87,940. This trade represents a ∞ increase in their position. The disclosure for this purchase can be found here. Insiders own 3.07% of the company's stock.
Analyst Upgrades and Downgrades
Several equities research analysts have issued reports on the company. Robert W. Baird cut their price target on Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a report on Thursday, May 8th. Needham & Company LLC cut their price target on Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a report on Thursday, May 8th. Mizuho raised their price target on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Finally, TD Cowen raised Genpact from a "hold" rating to a "buy" rating and raised their price target for the company from $45.00 to $60.00 in a report on Friday, February 7th. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $50.71.
View Our Latest Research Report on G
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Articles

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.